Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Merck
Colorcon
Boehringer Ingelheim

Last Updated: June 28, 2022

CLINICAL TRIALS PROFILE FOR CALFACTANT


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Calfactant

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00506532 ↗ The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study Unknown status Rabin Medical Center Phase 2/Phase 3 2005-01-01 1. Working Hypothesis: The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients. 2. Aims of the Study: The purpose of the trial is to study the effect of exogenous calf surfactant (calfactant) on the prevention of primary graft failure due to ischemic-reperfusion lung injury in lung transplant patients.
NCT00569530 ↗ Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide Completed Mallinckrodt Phase 3 2008-01-01 The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants.
NCT00569530 ↗ Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide Completed ONY Phase 3 2008-01-01 The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants.
NCT00569530 ↗ Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide Completed Roberta Ballard Phase 3 2008-01-01 The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants.
NCT00569530 ↗ Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide Completed University of California, San Francisco Phase 3 2008-01-01 The purpose of this study is to determine if the combination of late doses of Infasurf with inhaled nitric oxide will interact to improve the surfactant function and thus the respiratory status and outcome of treated infants.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Calfactant

Condition Name

Condition Name for Calfactant
Intervention Trials
Bronchopulmonary Dysplasia 4
Respiratory Distress Syndrome 2
Primary Graft Dysfunction 1
Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Calfactant
Intervention Trials
Bronchopulmonary Dysplasia 5
Respiratory Distress Syndrome, Adult 5
Respiratory Distress Syndrome, Newborn 4
Respiratory Distress Syndrome 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Calfactant

Trials by Country

Trials by Country for Calfactant
Location Trials
United States 62
Canada 3
Israel 2
New Zealand 2
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Calfactant
Location Trials
Texas 5
California 5
New York 5
Florida 4
Illinois 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Calfactant

Clinical Trial Phase

Clinical Trial Phase for Calfactant
Clinical Trial Phase Trials
Phase 3 4
Phase 2/Phase 3 2
Phase 2 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Calfactant
Clinical Trial Phase Trials
Completed 7
Unknown status 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Calfactant

Sponsor Name

Sponsor Name for Calfactant
Sponsor Trials
University of California, San Francisco 3
ONY 2
Roberta Ballard 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Calfactant
Sponsor Trials
Other 20
Industry 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Dow
Moodys
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.